AURORA CANNABIS INC (ACB) Stock Overview
NASDAQ:ACB - CA05156X8504 - Common Stock
ACB Key Statistics, Chart & Performance
The current stock price of ACB is 5.23 USD. In the past month the price increased by 9.41%. In the past year, price decreased by -13.98%.
ACB Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 43.05 | 658.10B | ||
| JNJ | JOHNSON & JOHNSON | 17.84 | 429.67B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 14.52 | 250.34B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 17.94 | 246.98B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 14.13 | 242.06B | ||
| MRK | MERCK & CO. INC. | 11.08 | 213.09B | ||
| PFE | PFIZER INC | 7.42 | 142.93B | ||
| SNY | SANOFI-ADR | 11.37 | 122.26B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 7 | 95.95B | ||
| GSK | GSK PLC-SPON ADR | 8.83 | 79.91B | ||
| ZTS | ZOETIS INC | 24.95 | 68.78B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 51.97 | 47.59B |
Related stock screener links
About ACB
Company Profile
Aurora Cannabis, Inc. engages in the production, distribution, and sale of cannabis and cannabis-derivative products. The company is headquartered in Leduc, Alberta and currently employs 1,073 full-time employees. The company went IPO on 2007-09-26. The Company’s principal business lines are focused on the production, distribution and sale of cannabis and cannabis-derivative products in Canada and internationally, and the propagation of vegetables and ornamental plants in North America. Its segments include Canadian Cannabis and Plant Propagation. The firm's adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol, IndiMed and CraftPlant. The company also has a controlling interest in Bevo Farms Ltd., North America's supplier of propagated vegetables and ornamental plants in North America. Its subsidiaries include Aurora Cannabis Enterprises Inc., Aurora Deutschland GmbH, TerraFarma Inc., Whistler Medical Marijuana Corporation, and Indica Industries Pty Ltd., among others.
Company Info
AURORA CANNABIS INC
2207 90B Street Sw
Leduc ALBERTA T5J 1Y6 CA
CEO: Terry Booth
Employees: 1073
Phone: 16043625207
AURORA CANNABIS INC / ACB FAQ
What is the stock price of AURORA CANNABIS INC today?
The current stock price of ACB is 5.23 USD. The price increased by 4.81% in the last trading session.
What is the ticker symbol for AURORA CANNABIS INC stock?
The exchange symbol of AURORA CANNABIS INC is ACB and it is listed on the Nasdaq exchange.
On which exchange is ACB stock listed?
ACB stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for AURORA CANNABIS INC stock?
9 analysts have analysed ACB and the average price target is 5.8 USD. This implies a price increase of 10.87% is expected in the next year compared to the current price of 5.23. Check the AURORA CANNABIS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is AURORA CANNABIS INC worth?
AURORA CANNABIS INC (ACB) has a market capitalization of 294.19M USD. This makes ACB a Micro Cap stock.
How many employees does AURORA CANNABIS INC have?
AURORA CANNABIS INC (ACB) currently has 1073 employees.
What are the support and resistance levels for AURORA CANNABIS INC (ACB) stock?
AURORA CANNABIS INC (ACB) has a support level at 4.89 and a resistance level at 5.41. Check the full technical report for a detailed analysis of ACB support and resistance levels.
Is AURORA CANNABIS INC (ACB) expected to grow?
The Revenue of AURORA CANNABIS INC (ACB) is expected to grow by 8.72% in the next year. Check the estimates tab for more information on the ACB EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy AURORA CANNABIS INC (ACB) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of ACB, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of ACB, evaluating the profitability, health, valuation and growth aspects
- AURORA CANNABIS INC (ACB) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- AURORA CANNABIS INC (ACB) Sales and EPS estimates to see what analysts future expectations are.
- AURORA CANNABIS INC (ACB) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- AURORA CANNABIS INC (ACB) Insider and Institutional Ownership to learn about the owners and their transactions.
- AURORA CANNABIS INC (ACB) Stock Chart to make your own analysis
- AURORA CANNABIS INC (ACB) Latest news and press-releases to stay up to date.
Does AURORA CANNABIS INC (ACB) stock pay dividends?
ACB does not pay a dividend.
When does AURORA CANNABIS INC (ACB) report earnings?
AURORA CANNABIS INC (ACB) will report earnings on 2025-11-04, before the market open.
What is the Price/Earnings (PE) ratio of AURORA CANNABIS INC (ACB)?
AURORA CANNABIS INC (ACB) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.25).
What is the Short Interest ratio of AURORA CANNABIS INC (ACB) stock?
The outstanding short interest for AURORA CANNABIS INC (ACB) is 10.07% of its float. Check the ownership tab for more information on the ACB short interest.
ACB Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to ACB. When comparing the yearly performance of all stocks, ACB is a bad performer in the overall market: 81.41% of all stocks are doing better.
ACB Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to ACB. ACB has a bad profitability rating. Also its financial health evaluation is rather negative.
ACB Financial Highlights
Over the last trailing twelve months ACB reported a non-GAAP Earnings per Share(EPS) of -0.25. The EPS increased by 44.79% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -2.32% | ||
| ROE | -3.53% | ||
| Debt/Equity | 0.07 |
ACB Forecast & Estimates
9 analysts have analysed ACB and the average price target is 5.8 USD. This implies a price increase of 10.87% is expected in the next year compared to the current price of 5.23.
For the next year, analysts expect an EPS growth of -288.53% and a revenue growth 8.72% for ACB